Stay updated with breaking news from Exception Access Regime. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article reviews the essential regulatory considerations surrounding medicines and medical devices in Argentina, including clinical trials and marketing authorisations.
To embed, copy and paste the code into your website or blog: The National Ministry of Health issued Resolution No. 654/2021 (hereinafter referred as the “Resolution”) This Resolution approved an Exception Access Regime for products that contain cannabinoids or derivatives of the cannabis plants devoted exclusively for medicinal uses in individual treatments or in the framework of scientific research. The Resolution states the cases in which the Exception Access Regime is applicable. In case of products for individual treatments whose import is authorized by the National Food, Drug and Med...